BNT162b2 Versus mRNA‐1273 Vaccines: Comparative Analysis of Long‐Term Protection Against SARS‐CoV‐2 Infection and Severe COVID‐19 in Qatar
<h3>Background</h3><p dir="ltr">This study provides a head‐to‐head comparison of the protection provided by the BNT162b2 and mRNA‐1273 vaccines against SARS‐CoV‐2 infection and against severe COVID‐19, covering primary series and third dose/booster vaccinations over up to...
محفوظ في:
مواد مشابهة
-
Short- and longer-term all-cause mortality among SARS-CoV-2- infected individuals and the pull-forward phenomenon in Qatar: a national cohort study
حسب: Hiam Chemaitelly (439114)
منشور في: (2023) -
Follow‐Up and Comparative Assessment of SARS‐CoV‐2 IgA, IgG, Neutralizing, and Total Antibody Responses After BNT162b2 or mRNA‐1273 Heterologous Booster Vaccination
حسب: Salma Younes (6424865)
منشور في: (2024) -
Short- and longer-term all-cause mortality among SARS-CoV-2- infected individuals and the pull-forward phenomenon in Qatar: a national cohort study
حسب: Hiam, Chemaitelly
منشور في: (2023) -
The initial impact of a national BNT162b2 mRNA COVID-19 vaccine rollout
حسب: Ahmed Zaqout (9538566)
منشور في: (2021) -
Addressing bias in the definition of SARS-CoV-2 reinfection: implications for underestimation
حسب: Hiam Chemaitelly (439114)
منشور في: (2024)